Open AccessHypertriglyceridemia in a COVID-19 Patient: A Case Report
Author(s) -
Alfateh Noor,
Zohdi Farea,
Shakya Majumder
Publication year - 2022
Publication title -
international journal of health sciences and research
Language(s) - English
Resource type - Journals
ISSN - 2249-9571
DOI - 10.52403/ijhsr.20220437
Subject(s) - plasmapheresis , medicine , hypertriglyceridemia , covid-19 , triglyceride , disease , intensive care medicine , pediatrics , infectious disease (medical specialty) , virology , immunology , cholesterol , outbreak , antibody
Most laboratory findings of coronavirus disease (COVID-19) are not specific nor are they reliable in assessing response to treatments. This case report outlines a rare finding of severe hypertriglyceridemia in a COVID-19 patient and, more interestingly, it sheds light on a correlation between clinical improvement and a decrease in hypertriglyceridemia after plasmapheresis treatment. Using a normal triglyceride level as a target for our plasmapheresis treatment resulted in dramatic improvement in our patient’s condition. The patient was treated successfully and discharged from the hospital after nine days.Key words: SARS-CoV-2, COVID-19, Hypertriglyceremia.